Mediators of Inflammation / 2012 / Article / Tab 3

Research Article

Distinct Proteasome Subpopulations in the Alveolar Space of Patients with the Acute Respiratory Distress Syndrome

Table 3

Characteristics of BAL in ARDS and healthy subjects.

ARDS patients ( )Healthy subjects ( ) value

Proteasome concentration in BAL supernatant [ng/mL]971 ± 111659 ± 25<0.001
Proteasome concentration in plasma [ng/mL]2855 ± 2422348 ± 126<0.001
Suc-LLVY-AMC proteasome activity in BAL supernatant [pkat/mg] <0.001
BZ-VGR-AMC proteasome activity in BAL supernatant [pkat/mg] <0.001
Suc-LLE-AMC proteasome activity in BAL supernatant [pkat/mg] 2 ± 1.20.002
Total protein concentration in BAL supernatant [mg/mL] <0.001
Albumin concentration in BAL supernatant [mg/mL]1.5 ± 3 0.0011
LDH in BAL supernatant [U/L]342 ± 77928 ± 9.70.024
LDH in plasma [U/L]821 ± 1104184 ± 53<0.001
Cell count in cell pellet [106/mL]330 ± 994 0.007
Macrophages [%] <0.001
Neutrophile granulocytes [%] <0.001
Lymphocytes [%] 0.056

Data are means ± SD.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.